WASHINGTON, DC – The campaign to align Medicare reimbursement rates with the market reality that HME suppliers are facing is ready to kick into high gear—and we need your support to help us get it off to a strong start.
Reps. Markwayne Mullin (R-Okla.) and Paul Tonko (D-N.Y.) have drafted legislation that applies a 90/10 blended Medicare reimbursement rate for items in the 13 product categories whose bid results were not implemented in Round 2021. These increased rates would apply from Jan. 1, 2022 through Dec. 31, 2023.
You can help this important legislation get off to a strong start by asking your Representative in the House to be an original co-sponsor for when introduced. A strong show of grassroots support at the open of this campaign will raise the visibility of this measure and re-affirm our industry’s passion and commitment to advocate for this legislation to our allies on the Hill. Here’s how to make that happen:
- The most effective way to support this legislation is to send a brief, personally drafted e-mail to your Representative’s staffer who deals with health care issues with a couple of sentences about the critical need to align Medicare reimbursement rates with the cost and operational environment our industry faces – and an ask that they serve as an original co-sponsor to this bill.
- You can find draft messaging and information about how to contact your legislators here, including details on finding the email for the staffer who handles healthcare issues for your Representative, as well a list of legislators who joined a House sign-on letter last November asking CMS to address Medicare reimbursements for HME.
- We also have a pre-drafted email that your colleagues and contacts can send via our Action Center.
The challenge is significant; passing legislation with a sizable budgetary impact is not easily accomplished. We’ll need our strongest, loudest, smartest advocacy campaign effort to succeed.
The HME community is prepared, united, and ready to win. Let’s get the campaign off to a strong start.